These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9753496)

  • 1. Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis.
    Guyader D; Jacquelinet C; Moirand R; Turlin B; Mendler MH; Chaperon J; David V; Brissot P; Adams P; Deugnier Y
    Gastroenterology; 1998 Oct; 115(4):929-36. PubMed ID: 9753496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive prediction of cirrhosis in C282Y-linked hemochromatosis.
    Beaton M; Guyader D; Deugnier Y; Moirand R; Chakrabarti S; Adams P
    Hepatology; 2002 Sep; 36(3):673-8. PubMed ID: 12198660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis.
    Morrison ED; Brandhagen DJ; Phatak PD; Barton JC; Krawitt EL; El-Serag HB; Gordon SC; Galan MV; Tung BY; Ioannou GN; Kowdley KV
    Ann Intern Med; 2003 Apr; 138(8):627-33. PubMed ID: 12693884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive assessment of liver fibrosis in C282Y homozygous HFE hemochromatosis.
    Legros L; Bardou-Jacquet E; Latournerie M; Guillygomarc'h A; Turlin B; Le Lan C; Désille Y; Lainé F; Moirand R; Brissot P; Deugnier Y; Guyader D
    Liver Int; 2015 Jun; 35(6):1731-8. PubMed ID: 25495562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis.
    Crawford DH; Murphy TL; Ramm LE; Fletcher LM; Clouston AD; Anderson GJ; Subramaniam VN; Powell LW; Ramm GA
    Hepatology; 2009 Feb; 49(2):418-25. PubMed ID: 19177571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of silent liver fibrosis in hemochromatosis C282Y homozygotes with normal transaminase levels.
    Beaton M; Adams PC
    Clin Gastroenterol Hepatol; 2008 Jun; 6(6):713-4. PubMed ID: 18550006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A population-based study of the clinical expression of the hemochromatosis gene.
    Olynyk JK; Cullen DJ; Aquilia S; Rossi E; Summerville L; Powell LW
    N Engl J Med; 1999 Sep; 341(10):718-24. PubMed ID: 10471457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of untreated hereditary hemochromatosis in the Busselton population: a 17-year study.
    Olynyk JK; Hagan SE; Cullen DJ; Beilby J; Whittall DE
    Mayo Clin Proc; 2004 Mar; 79(3):309-13. PubMed ID: 15008603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of liver fibrosis using FibroScan and other noninvasive methods in patients with hemochromatosis: a prospective study.
    Adhoute X; Foucher J; Laharie D; Terrebonne E; Vergniol J; Castéra L; Lovato B; Chanteloup E; Merrouche W; Couzigou P; de Lédinghen V
    Gastroenterol Clin Biol; 2008 Feb; 32(2):180-7. PubMed ID: 18496894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron-overload-related disease in HFE hereditary hemochromatosis.
    Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
    N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The diagnosis of hemochromatosis in the era of the gene].
    Brissot P; Moirand R; Guyader D; Jouanolle AM; David V; Deugnier Y
    Ann Endocrinol (Paris); 1999 Sep; 60(3):210-5. PubMed ID: 10520412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HFE genotype in patients with hemochromatosis and other liver diseases.
    Bacon BR; Olynyk JK; Brunt EM; Britton RS; Wolff RK
    Ann Intern Med; 1999 Jun; 130(12):953-62. PubMed ID: 10383365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of HLA-linked hemochromatosis in subjects homozygous or heterozygous for the C282Y mutation.
    Crawford DH; Jazwinska EC; Cullen LM; Powell LW
    Gastroenterology; 1998 May; 114(5):1003-8. PubMed ID: 9558290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C.
    Smith BC; Gorve J; Guzail MA; Day CP; Daly AK; Burt AD; Bassendine MF
    Hepatology; 1998 Jun; 27(6):1695-9. PubMed ID: 9620344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum ferritin concentration predicts hepatic fibrosis better than hepatic iron concentration in human HFE-Haemochromatosis.
    Wood MJ; Crawford DHG; Wockner LF; Powell LW; Ramm GA
    Liver Int; 2017 Sep; 37(9):1382-1388. PubMed ID: 28231420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HFE gene mutation (C282Y) and phenotypic expression among a hospitalised population in a high prevalence area of haemochromatosis.
    Distante S; Berg JP; Lande K; Haug E; Bell H
    Gut; 2000 Oct; 47(4):575-9. PubMed ID: 10986220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
    Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD
    Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of genome-wide loci of iron metabolism in hereditary hemochromatosis identifies PCSK7 as a host risk factor of liver cirrhosis.
    Stickel F; Buch S; Zoller H; Hultcrantz R; Gallati S; Österreicher C; Finkenstedt A; Stadlmayr A; Aigner E; Sahinbegovic E; Sarrazin C; Schafmayer C; Braun F; Erhart W; Nothnagel M; Lerch MM; Mayerle J; Völzke H; Schaller A; Kratzer W; Boehm BO; Sipos B; D'Amato M; Torkvist L; Stal P; Arlt A; Franke A; Becker T; Krawczak M; Zwerina J; Berg T; Hinrichsen H; Krones E; Dejaco C; Strasser M; Datz C; Hampe J
    Hum Mol Genet; 2014 Jul; 23(14):3883-90. PubMed ID: 24556216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of the metabolic syndrome, hepatic steatosis and steatohepatitis on liver fibrosis in hereditary hemochromatosis.
    Adams LA; Angulo P; Abraham SC; Torgerson H; Brandhagen D
    Liver Int; 2006 Apr; 26(3):298-304. PubMed ID: 16584391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there a threshold of hepatic iron concentration that leads to cirrhosis in C282Y hemochromatosis?
    Adams PC
    Am J Gastroenterol; 2001 Feb; 96(2):567-9. PubMed ID: 11232708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.